Passage Bio
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $3,212 |
Gross Profit | -200 | -201 | -719 | |
EBITDA | -7,439 | -9,185 | -13,621 | -12,306 |
EBIT | -7,749 | -9,385 | -13,822 | -13,025 |
Net Income | -7,749 | -9,385 | -15,405 | -12,725 |
Net Change In Cash | 0 | 0 | 0 | 3,212 |
Free Cash Flow | -4,853 | -6,330 | -13,847 | -8,458 |
Cash | 52,773 | 57,626 | 63,357 | 37,573 |
Basic Shares | 3,168 | 3,168 | 3,105 | 3,103 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,081 | -3,721 | -3,679 | -1,543 |
EBITDA | -62,086 | -98,341 | -131,715 | -176,186 |
EBIT | -65,167 | -102,062 | -135,394 | -177,729 |
Net Income | -64,767 | -102,062 | -136,125 | -185,386 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -94,364 | -6,037 | ||
Free Cash Flow | -47,990 | -78,410 | -123,484 | -152,521 |
Cash | 37,573 | 21,709 | 34,601 | 128,965 |
Basic Shares | 3,020 | 2,737 | 2,721 | 2,667 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.44 |
2025-06-30 | -$2.96 |
2025-03-31 | -$0.25 |
2024-12-31 | -$0.20 |
